Related Experiment Video
Updated: Feb 10, 2026

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Endogenous authentic OCT4A proteins directly regulate FOS/AP-1 transcription in somatic cancer cells
Yanwen Zhou1,2, Xinyu Chen1, Bo Kang1
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China.
Abstract:
OCT4A is well established as a master transcription factor for pluripotent stem cell (PSC) self-renewal and a pioneer factor for initiating somatic cell reprogramming, yet its presence and functionality in somatic cancer cells remain controversial and obscure. By combining the CRISPR-Cas9-based gene editing with highly specific PCR assays, highly sensitive immunoassays, and mass spectrometry, we provide unequivocal evidence here that full-length authentic OCT4A transcripts and proteins were both present in somatic cancer cells, and OCT4A proteins were heterogeneously expressed in the whole cell population and when expressed, they are predominantly localized in cell nucleus. Despite their extremely low abundance (approximately three orders of magnitude lower than in PSCs), OCT4A proteins bound to the promoter/enhancer regions of the AP-1 transcription factor subunit c-FOS gene and critically regulated its transcription. Knocking out OCT4A in somatic cancer cells led to dramatic reduction of the c-FOS protein level, aberrant AP-1 signaling, dampened self-renewal capacity, deficient cell migration that were associated with cell growth retardation in vitro and in vivo, and their enhanced sensitivity to anticancer drugs. Taken together, we resolve the long-standing controversy and uncertainty in the field, and reveal a fundamental role of OCT4A protein in regulating FOS/AP-1 signaling-centered genes that mediate the adhesion, migration, and propagation of somatic cancer cells.
Insights
Octamer-binding transcription factor 4 variant A (OCT4A) is present in cancer cells, regulating genes crucial for tumor growth and migration. Its inhibition hinders cancer cell propagation and increases sensitivity to drugs.
Area of Science:
- Molecular Biology
- Cancer Biology
- Stem Cell Biology
Background:
- Octamer-binding transcription factor 4 variant A (OCT4A) is a key regulator in pluripotent stem cells (PSCs) and reprogramming.
- Its role in somatic cancer cells remains controversial and poorly understood.
Purpose of the Study:
- To investigate the presence and function of OCT4A in somatic cancer cells.
- To elucidate OCT4A's role in cancer cell biology and its potential as a therapeutic target.
Main Methods:
- CRISPR-Cas9 gene editing
- Specific PCR assays
- Sensitive immunoassays
- Mass spectrometry
Main Results:
- Unequivocal evidence of full-length OCT4A transcripts and proteins in somatic cancer cells, predominantly nuclear localization.
- Low-abundance OCT4A proteins regulate c-FOS transcription, impacting AP-1 signaling, self-renewal, and migration.
- OCT4A knockout reduced c-FOS, impaired AP-1 signaling, decreased self-renewal and migration, retarded growth in vitro/in vivo, and enhanced drug sensitivity.
Conclusions:
- Resolves controversy regarding OCT4A presence and function in cancer cells.
- Reveals a fundamental role of OCT4A in regulating FOS/AP-1 signaling for cancer cell adhesion, migration, and propagation.
- Suggests OCT4A as a potential therapeutic target for enhancing anti-cancer drug efficacy.
More Related Videos
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Cooperative Binding of Transcription Regulators
Cooperative Binding of Transcription Regulators
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Cancers Originate from Somatic Mutations in a Single Cell

